 <h1>Arthrotec Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>diclofenac / misoprostol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about diclofenac / misoprostol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Arthrotec.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to diclofenac / misoprostol: oral tablet enteric coated</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet; Tablet, Enteric Coated)</p><p>Diclofenac sodium/misoprostol should not be administered during pregnancy as abortion, premature birth, birth defects, or uterine rupture can occur. The risk of uterine rupture increases with advancing gestational ages and with prior uterine surgery, including cesarean delivery. Avoid use in women of childbearing potential unless the patient requires NSAID therapy and is at high risk of developing complications from gastric or duodenal ulcers and meets the following criteria: has a negative serum pregnancy test within 2 weeks of treatment initiation, uses effective contraception, receives oral and written warnings of the hazards of misoprostol, and initiates therapy only on the second or third day of her next normal menstrual period. NSAIDs cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use. Diclofenac sodium/misoprostol is contraindicated in the setting of CABG surgery. NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, diclofenac / misoprostol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking diclofenac / misoprostol:</p><p>
<i>More common</i>
</p><ul>
<li>Stomach pain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bladder pain</li>
<li>bloody or cloudy urine</li>
<li>burning feeling in the chest or stomach</li>
<li>burning while urinating</li>
<li>chest pain, discomfort, or tightness</li>
<li>chills</li>
<li>cough</li>
<li>deep or fast breathing with dizziness</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty swallowing</li>
<li>dizziness</li>
<li>double vision</li>
<li>feeling of constant movement of self or surroundings</li>
<li>fever</li>
<li>frequent urge to urinate</li>
<li>heartburn</li>
<li>increased sensitivity of the skin to sunlight</li>
<li>increased volume of pale, dilute urine</li>
<li>indigestion</li>
<li>itching, skin rash</li>
<li>lightheadedness</li>
<li>longer or heavier menstrual periods</li>
<li>lower back or side pain</li>
<li>nosebleed</li>
<li>numbness of the feet, hands, and around the mouth</li>
<li>pain or burning in the throat</li>
<li>pain with swallowing</li>
<li>redness or other discoloration of the skin</li>
<li>seeing double</li>
<li>sensation of spinning</li>
<li>severe sunburn</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>sore throat</li>
<li>stomach upset or tenderness</li>
<li>swollen glands</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vaginal bleeding</li>
<li>vomiting with or without blood</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Ankle, knee, or great toe joint pain</li>
<li>anxiety</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>blindness</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>bluish color of the skin</li>
<li>blurred vision</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>burning, dry, or itching eyes</li>
<li>cloudy or dark urine</li>
<li>decreased frequency or amount of urine</li>
<li>decreased vision</li>
<li>diarrhea</li>
<li>difficulty in speaking</li>
<li>dilated neck veins</li>
<li>discharge, excessive tearing</li>
<li>dizziness, fainting, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>drowsiness</li>
<li>excessive muscle tone</li>
<li>extreme tiredness or weakness</li>
<li>eye pain</li>
<li>fainting</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>general feeling of illness</li>
<li>headache, severe and throbbing</li>
<li>hoarseness</li>
<li>inability to move the arms, legs, or facial muscles</li>
<li>inability to speak</li>
<li>increased sensitivity to pain or touch</li>
<li>increased thirst</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>joint pain, stiffness, or swelling</li>
<li>large, hive-like swelling on the pain, face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>light-colored stools</li>
<li>lightheadedness</li>
<li>loss of appetite</li>
<li>loss of consciousness</li>
<li>muscle stiffness, tension, or tightness</li>
<li>nausea</li>
<li>nervousness</li>
<li>night blindness</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
<li>pain, warmth, or burning in the fingers, toes, and legs</li>
<li>pale or blue lips, fingernails, or skin pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>pounding in the ears</li>
<li>problems with vision or hearing</li>
<li>rapid weight gain</li>
<li>red skin lesions, often with a purple center</li>
<li>redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>redness or soreness of the skin</li>
<li>seizures</li>
<li>severe stomach cramping</li>
<li>slow heartbeat</li>
<li>slow speech</li>
<li>sneezing</li>
<li>sores, welts, or blisters</li>
<li>stiff neck or back</li>
<li>tremor</li>
<li>trouble breathing</li>
<li>unusual bleeding or bruising</li>
<li>unusual weight gain or loss</li>
<li>upper right stomach pain</li>
<li>uterine cramping and bleeding</li>
<li>vomiting of material that looks like coffee grounds, severe and continuing</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of diclofenac / misoprostol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Belching</li>
<li>excess air or gas in the stomach or bowels</li>
<li>full feeling</li>
<li>passing gas</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Breast pain</li>
<li>change in or loss of taste</li>
<li>confusion about identity, place, and time</li>
<li>constipation</li>
<li>continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>decreased concentration</li>
<li>depression</li>
<li>difficulty in moving</li>
<li>dry mouth</li>
<li>frequent urge to defecate</li>
<li>increased clear or white vaginal discharge</li>
<li>irritability</li>
<li>itching of the vagina or genital area</li>
<li>lack or loss of strength</li>
<li>loss or thinning of hair</li>
<li>pain during sexual intercourse</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>straining while passing stool</li>
<li>thick, white vaginal discharge with no odor or with a mild odor</li>
<li>trouble sleeping</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blemishes on the skin</li>
<li>decreased interest in sexual intercourse</li>
<li>inability to have or keep an erection</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>pimples</li>
<li>sleepiness or unusual drowsiness</li>
</ul><p>
<!-- end oral tablet enteric coated --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to diclofenac / misoprostol: oral tablet</i></p><h3>General</h3><p>The highest reported incidences of adverse events for this drug were gastrointestinal and included abdominal pain, diarrhea, dyspepsia, nausea, and flatulence.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>NSAIDs including this drug, can cause serious gastrointestinal (GI) events which can occur at any time, with or without warning.  For patients who develop a serious upper GI event, only about 20% were symptomatic.  Upper GI ulcers, gross bleeding, or perforation occurred in approximately 1% of patients treated with NSAIDs for 3 to 6 months and 2% to 4% of patients treated for 1 year.  Patients with a prior history of peptic ulcer disease and/or GI bleeding had a greater than 10-fold increased risk for developing a GI bleed than patients with neither of these risk factors.<sup>[Ref]</sup></p><p>Diclofenac-misoprostol: </p>
<p><b>Very common</b> (10% or more): Abdominal pain (21%), diarrhea (19%), dyspepsia (14%), nausea (11%)</p>
<p><b>Common</b> (1% to 10%): Flatulence, gastritis, vomiting, eructation, constipation, peptic ulcer</p>
<p><b>Uncommon</b> (0.1% to 1%): Stomatitis</p>
<p><b>Rare</b> (less than 0.1%): Esophageal ulceration, esophagitis, gastroesophageal reflux, heartburn, hematemesis, melena, gall bladder disorder</p>
<p><b>Frequency not reported</b>: Pancreatitis</p>
<p><b>Postmarketing reports</b>: Gastrointestinal (GI) perforation, GI bleeding, melena, colitis, Crohn's disease, esophageal disorder, mouth ulceration, tongue edema, dry mouth</p>
<p></p>
<p>Diclofenac:</p>
<p><b>Very common</b> (10% or more): Abdominal pain (15%), diarrhea (11%), dyspepsia (11%), nausea (11%)</p>
<p><b>Common</b> (1% to 10%): Flatulence, nausea<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Hypertension, chest pain, edema, palpitation, syncope</p>
<p><b>Rare</b> (less than 0.1%): Arrhythmia, atrial fibrillation, hypotension, myocardial infarction, premature ventricular contractions, tachycardia, vasculitis, phlebitis</p>
<p><b>Frequency not reported</b>: Cardiac failure, palpitations<sup>[Ref]</sup></p><p>Clinical trials of several cyclooxygenase (COX)-2 selective and nonselective NSAIDs of up to 3 years duration have shown an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal.  All NSAIDs appear to have a similar risk.  There is no consistent evidence that concurrent use of aspirin mitigates this increased risk and may be associated with an increased risk of serious gastrointestinal events.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Alanine aminotransferase increased, aspartate aminotransferase increased</p>
<p><b>Rare</b> (less than 0.1%): Hepatitis, jaundice, abnormal hepatic function</p>
<p><b>Frequency not reported</b>: Liver failure</p>
<p><b>Postmarketing reports</b>: Hepatitis fulminant, blood bilirubin increased<sup>[Ref]</sup></p><p>Elevations to greater than 3 x ULN of ALT occurred in about 1.6% (n=2184) of patients receiving diclofenac-misoprostol at some point during treatment.  These increases were generally transient and returned to within normal range upon discontinuation of therapy.  In an open-labeled trial among patients receiving NSAIDs, a higher incidence of transaminase elevations were observed in patients receiving diclofenac compared with other NSAIDs.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Allergic reactions</p>
<p><b>Frequency not reported</b>: Angioedema, laryngeal/pharyngeal edema, urticaria</p>
<p><b>Postmarketing reports</b>: Anaphylaxis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Erythema multiforme, rash, pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Purpura, urticaria</p>
<p><b>Rare</b> (less than 0.1%): Angioedema, increased sweating, acne</p>
<p><b>Postmarketing reports</b>: Toxic epidermal necrolysis, Stevens-Johnson syndrome, dermatitis exfoliative, dermatitis bullous, Henoch Schonlein purpura, mucocutaneous rash, rash vesicular, photosensitivity reaction, alopecia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal failure, glomerulonephritis membranous, glomerulonephritis minimal lesion</p>
<p><b>Postmarketing reports</b>: Acute renal failure, renal papillary necrosis, nephritis, interstitial nephrotic syndrome, proteinuria<sup>[Ref]</sup></p><h3>Hematologic</h3><p>NSAIDs inhibit platelet aggregation and have been shown to prolong bleeding time in some patients.  Unlike aspirin, the NSAID effect on platelet function is quantitatively less, of shorter duration, and reversible.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia </p>
<p><b>Rare</b> (less than 0.1%): Agranulocytosis, anemia, aplastic anemia, coagulation time increased, ecchymosis, eosinophilia, hemolytic anemia, leukocytosis, leukopenia, lymphadenopathy, pancytopenia, decreased hematocrit<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (less than 0.1%): Anorexia, appetite changes, dehydration, hyperglycemia, hypoglycemia, hyponatremia, weight changes, gout, hypercholesterolemia, porphyria<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p>
<p><b>Rare</b> (less than 0.1%): Drowsiness, headache, hyperesthesia, hypertonia, hypoesthesia, insomnia, meningitis, migraine, neuralgia, paresthesia, somnolence, stroke, tremor, confusion</p>
<p><b>Frequency not reported</b>: Coma </p>
<p><b>Postmarketing reports</b>: Convulsions, memory disturbance, taste disturbance<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia</p>
<p><b>Rare</b> (less than 0.1%): Anxiety, impaired concentration, depression, dream abnormalities, hallucinations, irritability, nervousness, paranoia, psychotic reaction</p>
<p><b>Postmarketing reports</b>: Mood changes, nightmares<sup>[Ref]</sup></p><h3>Other</h3><p><b>Rare</b> (less than 0.1%): Asthenia, fatigue, fever, malaise, chills, hearing impairment, tinnitus, speech disorder<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Misoprostol may cause abortion.  It has been used outside of its approved indications to ripen the cervix, to induce labor, and to treat postpartum hemorrhage, however a major adverse effect of these uses is hyperstimulation of the uterus.  Uterine rupture, amniotic fluid embolism, and severe genital bleeding have been reported.<sup>[Ref]</sup></p><p>Diclofenac-misoprostol: </p>
<p><b>Rare</b> (less than 0.1%): Vaginitis, menstrual disorder, menorrhagia, dysmenorrhea, intermenstrual bleeding, cystitis, dysuria, nocturia </p>
<p><b>Frequency not reported</b>: Impotence, perineal pain </p>
<p><b>Postmarketing reports</b>: Intrauterine death, uterine rupture, incomplete abortion, abnormal uterine contractions, retained placenta, dysuria, urine abnormal</p>
<p></p>
<p>Misoprostol: </p>
<p><b>Frequency not reported</b>: Hyperstimulation of the uterus, amniotic fluid embolism resulting in maternal and fetal death, severe vaginal bleeding, retained placenta, pelvic pain, uterine rupture<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Amblyopia, blurred vision, conjunctivitis, diplopia, glaucoma, iritis, lacrimation abnormal, night blindness, abnormal vision, eye pain<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (less than 0.1%): Coughing, dyspnea, hyperventilation, pneumonia, respiratory depression, pharyngitis, increased sputum</p>
<p><b>Postmarketing reports</b>: Asthma, pneumonitis, dyspnea<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Infection, sepsis</p>
<p><b>Postmarketing reports</b>: Aseptic meningitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Arthralgia, myalgia, leg cramps<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Arthrotec (diclofenac-misoprostol)." Searle, Skokie, IL. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Arthrotec (diclofenac / misoprostol)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>41 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: Nonsteroidal anti-inflammatory drugs</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Arthrotec &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Osteoarthritis</li>
<li>Sciatica</li>
<li>Rheumatoid Arthritis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to diclofenac / misoprostol: oral tablet</i></p><h3>General</h3><p>The highest reported incidences of adverse events for this drug were gastrointestinal and included abdominal pain, diarrhea, dyspepsia, nausea, and flatulence.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>NSAIDs including this drug, can cause serious gastrointestinal (GI) events which can occur at any time, with or without warning.  For patients who develop a serious upper GI event, only about 20% were symptomatic.  Upper GI ulcers, gross bleeding, or perforation occurred in approximately 1% of patients treated with NSAIDs for 3 to 6 months and 2% to 4% of patients treated for 1 year.  Patients with a prior history of peptic ulcer disease and/or GI bleeding had a greater than 10-fold increased risk for developing a GI bleed than patients with neither of these risk factors.<sup>[Ref]</sup></p><p>Diclofenac-misoprostol: </p><p><b>Very common</b> (10% or more): Abdominal pain (21%), diarrhea (19%), dyspepsia (14%), nausea (11%)</p><p><b>Common</b> (1% to 10%): Flatulence, gastritis, vomiting, eructation, constipation, peptic ulcer</p><p><b>Uncommon</b> (0.1% to 1%): Stomatitis</p><p><b>Rare</b> (less than 0.1%): Esophageal ulceration, esophagitis, gastroesophageal reflux, heartburn, hematemesis, melena, gall bladder disorder</p><p><b>Frequency not reported</b>: Pancreatitis</p><p><b>Postmarketing reports</b>: Gastrointestinal (GI) perforation, GI bleeding, melena, colitis, Crohn's disease, esophageal disorder, mouth ulceration, tongue edema, dry mouth</p><p></p><p>Diclofenac:</p><p><b>Very common</b> (10% or more): Abdominal pain (15%), diarrhea (11%), dyspepsia (11%), nausea (11%)</p><p><b>Common</b> (1% to 10%): Flatulence, nausea<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Hypertension, chest pain, edema, palpitation, syncope</p><p><b>Rare</b> (less than 0.1%): Arrhythmia, atrial fibrillation, hypotension, myocardial infarction, premature ventricular contractions, tachycardia, vasculitis, phlebitis</p><p><b>Frequency not reported</b>: Cardiac failure, palpitations<sup>[Ref]</sup></p><p>Clinical trials of several cyclooxygenase (COX)-2 selective and nonselective NSAIDs of up to 3 years duration have shown an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal.  All NSAIDs appear to have a similar risk.  There is no consistent evidence that concurrent use of aspirin mitigates this increased risk and may be associated with an increased risk of serious gastrointestinal events.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Alanine aminotransferase increased, aspartate aminotransferase increased</p><p><b>Rare</b> (less than 0.1%): Hepatitis, jaundice, abnormal hepatic function</p><p><b>Frequency not reported</b>: Liver failure</p><p><b>Postmarketing reports</b>: Hepatitis fulminant, blood bilirubin increased<sup>[Ref]</sup></p><p>Elevations to greater than 3 x ULN of ALT occurred in about 1.6% (n=2184) of patients receiving diclofenac-misoprostol at some point during treatment.  These increases were generally transient and returned to within normal range upon discontinuation of therapy.  In an open-labeled trial among patients receiving NSAIDs, a higher incidence of transaminase elevations were observed in patients receiving diclofenac compared with other NSAIDs.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Allergic reactions</p><p><b>Frequency not reported</b>: Angioedema, laryngeal/pharyngeal edema, urticaria</p><p><b>Postmarketing reports</b>: Anaphylaxis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Erythema multiforme, rash, pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Purpura, urticaria</p><p><b>Rare</b> (less than 0.1%): Angioedema, increased sweating, acne</p><p><b>Postmarketing reports</b>: Toxic epidermal necrolysis, Stevens-Johnson syndrome, dermatitis exfoliative, dermatitis bullous, Henoch Schonlein purpura, mucocutaneous rash, rash vesicular, photosensitivity reaction, alopecia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Renal failure, glomerulonephritis membranous, glomerulonephritis minimal lesion</p><p><b>Postmarketing reports</b>: Acute renal failure, renal papillary necrosis, nephritis, interstitial nephrotic syndrome, proteinuria<sup>[Ref]</sup></p><h3>Hematologic</h3><p>NSAIDs inhibit platelet aggregation and have been shown to prolong bleeding time in some patients.  Unlike aspirin, the NSAID effect on platelet function is quantitatively less, of shorter duration, and reversible.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia </p><p><b>Rare</b> (less than 0.1%): Agranulocytosis, anemia, aplastic anemia, coagulation time increased, ecchymosis, eosinophilia, hemolytic anemia, leukocytosis, leukopenia, lymphadenopathy, pancytopenia, decreased hematocrit<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (less than 0.1%): Anorexia, appetite changes, dehydration, hyperglycemia, hypoglycemia, hyponatremia, weight changes, gout, hypercholesterolemia, porphyria<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Rare</b> (less than 0.1%): Drowsiness, headache, hyperesthesia, hypertonia, hypoesthesia, insomnia, meningitis, migraine, neuralgia, paresthesia, somnolence, stroke, tremor, confusion</p><p><b>Frequency not reported</b>: Coma </p><p><b>Postmarketing reports</b>: Convulsions, memory disturbance, taste disturbance<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia</p><p><b>Rare</b> (less than 0.1%): Anxiety, impaired concentration, depression, dream abnormalities, hallucinations, irritability, nervousness, paranoia, psychotic reaction</p><p><b>Postmarketing reports</b>: Mood changes, nightmares<sup>[Ref]</sup></p><h3>Other</h3><p><b>Rare</b> (less than 0.1%): Asthenia, fatigue, fever, malaise, chills, hearing impairment, tinnitus, speech disorder<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Misoprostol may cause abortion.  It has been used outside of its approved indications to ripen the cervix, to induce labor, and to treat postpartum hemorrhage, however a major adverse effect of these uses is hyperstimulation of the uterus.  Uterine rupture, amniotic fluid embolism, and severe genital bleeding have been reported.<sup>[Ref]</sup></p><p>Diclofenac-misoprostol: </p><p><b>Rare</b> (less than 0.1%): Vaginitis, menstrual disorder, menorrhagia, dysmenorrhea, intermenstrual bleeding, cystitis, dysuria, nocturia </p><p><b>Frequency not reported</b>: Impotence, perineal pain </p><p><b>Postmarketing reports</b>: Intrauterine death, uterine rupture, incomplete abortion, abnormal uterine contractions, retained placenta, dysuria, urine abnormal</p><p></p><p>Misoprostol: </p><p><b>Frequency not reported</b>: Hyperstimulation of the uterus, amniotic fluid embolism resulting in maternal and fetal death, severe vaginal bleeding, retained placenta, pelvic pain, uterine rupture<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Amblyopia, blurred vision, conjunctivitis, diplopia, glaucoma, iritis, lacrimation abnormal, night blindness, abnormal vision, eye pain<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (less than 0.1%): Coughing, dyspnea, hyperventilation, pneumonia, respiratory depression, pharyngitis, increased sputum</p><p><b>Postmarketing reports</b>: Asthma, pneumonitis, dyspnea<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Infection, sepsis</p><p><b>Postmarketing reports</b>: Aseptic meningitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Arthralgia, myalgia, leg cramps<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Arthrotec (diclofenac-misoprostol)." Searle, Skokie, IL. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Arthrotec (diclofenac / misoprostol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>41 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: Nonsteroidal anti-inflammatory drugs</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Arthrotec &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Osteoarthritis</li>
<li>Sciatica</li>
<li>Rheumatoid Arthritis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>